HK1053648A1 - Novel 1-(1-(hetero)aryl-1-perhydroxyalkylmethyl)-piperazine compounds, process for their preparationand medicaments containing these compounds - Google Patents
Novel 1-(1-(hetero)aryl-1-perhydroxyalkylmethyl)-piperazine compounds, process for their preparationand medicaments containing these compoundsInfo
- Publication number
- HK1053648A1 HK1053648A1 HK03105680A HK03105680A HK1053648A1 HK 1053648 A1 HK1053648 A1 HK 1053648A1 HK 03105680 A HK03105680 A HK 03105680A HK 03105680 A HK03105680 A HK 03105680A HK 1053648 A1 HK1053648 A1 HK 1053648A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- compounds
- perhydroxyalkylmethyl
- preparationand
- hetero
- aryl
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/092—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings with aromatic radicals attached to the chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10145044A DE10145044A1 (de) | 2001-09-13 | 2001-09-13 | Neue 1-[1-(Hetero)aryl-1-perhydroxyalkylmethyl]-Piperazinverbindungen, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1053648A1 true HK1053648A1 (en) | 2003-10-31 |
Family
ID=7698848
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK03105680A HK1053648A1 (en) | 2001-09-13 | 2003-08-08 | Novel 1-(1-(hetero)aryl-1-perhydroxyalkylmethyl)-piperazine compounds, process for their preparationand medicaments containing these compounds |
Country Status (27)
Country | Link |
---|---|
US (1) | US6770649B2 (xx) |
EP (1) | EP1293506B1 (xx) |
JP (1) | JP4353684B2 (xx) |
KR (1) | KR100909746B1 (xx) |
CN (1) | CN1232513C (xx) |
AR (1) | AR036487A1 (xx) |
AT (1) | ATE305464T1 (xx) |
AU (1) | AU2002301141B2 (xx) |
BR (1) | BR0203716A (xx) |
CA (1) | CA2403139C (xx) |
DE (2) | DE10145044A1 (xx) |
DK (1) | DK1293506T3 (xx) |
DZ (1) | DZ3292A1 (xx) |
ES (1) | ES2250561T3 (xx) |
HK (1) | HK1053648A1 (xx) |
HU (1) | HU227612B1 (xx) |
IL (1) | IL151497A (xx) |
MX (1) | MXPA02008789A (xx) |
NO (1) | NO324867B1 (xx) |
NZ (1) | NZ521154A (xx) |
PL (1) | PL356018A1 (xx) |
PT (1) | PT1293506E (xx) |
RU (1) | RU2301807C2 (xx) |
SI (1) | SI1293506T1 (xx) |
TW (1) | TWI254046B (xx) |
UA (1) | UA75590C2 (xx) |
ZA (1) | ZA200206731B (xx) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4918031B2 (ja) * | 2005-03-31 | 2012-04-18 | 日本臓器製薬株式会社 | ベンジルオキシプロピルアミン誘導体 |
JP2009517443A (ja) * | 2005-11-30 | 2009-04-30 | ゾルファイ ファーマスーティカルズ ゲゼルシャフト ミット ベシュレンクテル ハフツング | 新規のnk1およびnk2拮抗薬 |
US7592344B2 (en) | 2005-11-30 | 2009-09-22 | Solvay Pharmaceuticals Gmbh | NK1 and NK2-antagonists and compositions and methods of using the same |
CN103387549A (zh) * | 2012-05-10 | 2013-11-13 | 广州医学院 | 三个苯并三氮唑类芳基哌嗪化合物的消旋体和光学异构体及其制备方法和用途 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE903957A1 (en) * | 1989-11-06 | 1991-05-08 | Sanofi Sa | Aromatic amine compounds, their method of preparation and¹pharmaceutical compositions in which they are present |
IL99320A (en) * | 1990-09-05 | 1995-07-31 | Sanofi Sa | Arylalkylamines, their preparation and pharmaceutical preparations containing them |
EP0709375B1 (en) * | 1994-10-25 | 2005-05-18 | AstraZeneca AB | Therapeutic heterocycles |
AU2001244999A1 (en) * | 2000-04-06 | 2001-10-23 | Astrazeneca Ab | Naphthamide neurokinin antagonists for use as medicaments |
-
2000
- 2000-09-14 DZ DZ020227A patent/DZ3292A1/fr active
-
2001
- 2001-09-13 DE DE10145044A patent/DE10145044A1/de not_active Withdrawn
-
2002
- 2002-08-15 TW TW091118380A patent/TWI254046B/zh not_active IP Right Cessation
- 2002-08-22 AR ARP020103153A patent/AR036487A1/es active IP Right Grant
- 2002-08-22 ZA ZA200206731A patent/ZA200206731B/xx unknown
- 2002-08-27 IL IL151497A patent/IL151497A/en not_active IP Right Cessation
- 2002-09-03 NZ NZ521154A patent/NZ521154A/en not_active IP Right Cessation
- 2002-09-06 KR KR1020020053771A patent/KR100909746B1/ko not_active IP Right Cessation
- 2002-09-07 PT PT02020115T patent/PT1293506E/pt unknown
- 2002-09-07 DE DE50204379T patent/DE50204379D1/de not_active Expired - Lifetime
- 2002-09-07 SI SI200230195T patent/SI1293506T1/sl unknown
- 2002-09-07 EP EP02020115A patent/EP1293506B1/de not_active Expired - Lifetime
- 2002-09-07 DK DK02020115T patent/DK1293506T3/da active
- 2002-09-07 AT AT02020115T patent/ATE305464T1/de active
- 2002-09-07 ES ES02020115T patent/ES2250561T3/es not_active Expired - Lifetime
- 2002-09-09 MX MXPA02008789A patent/MXPA02008789A/es active IP Right Grant
- 2002-09-09 HU HU0202967A patent/HU227612B1/hu not_active IP Right Cessation
- 2002-09-11 CN CNB021315566A patent/CN1232513C/zh not_active Expired - Fee Related
- 2002-09-11 UA UA2002097386A patent/UA75590C2/uk unknown
- 2002-09-11 JP JP2002265969A patent/JP4353684B2/ja not_active Expired - Fee Related
- 2002-09-12 BR BR0203716-5A patent/BR0203716A/pt not_active IP Right Cessation
- 2002-09-12 PL PL02356018A patent/PL356018A1/xx not_active Application Discontinuation
- 2002-09-12 AU AU2002301141A patent/AU2002301141B2/en not_active Ceased
- 2002-09-12 RU RU2002124199/04A patent/RU2301807C2/ru not_active IP Right Cessation
- 2002-09-12 NO NO20024351A patent/NO324867B1/no not_active IP Right Cessation
- 2002-09-13 US US10/242,678 patent/US6770649B2/en not_active Expired - Lifetime
- 2002-09-13 CA CA2403139A patent/CA2403139C/en not_active Expired - Fee Related
-
2003
- 2003-08-08 HK HK03105680A patent/HK1053648A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL375316A1 (en) | Process for preparing certain pyrrolotriazine compounds | |
HK1081965A1 (en) | Pyridopyrimidinone compounds, method for production thereof and medicaments comprising the same | |
IL164442A0 (en) | Benzoxazinone-derived compounds, their preparationand use as medicaments | |
IL150377A0 (en) | Substituted piperidines, medicaments containing these compounds, and methods for the production thereof | |
AU2002333415A1 (en) | Process for preparing 1-(carboxymethyl)- and 1-(aminocarbonyl)- pyrimidin-4-one derivatives | |
MXPA03006322A (es) | Procedimiento mejorado para la sintesis de carbapenem. | |
HUP0500037A3 (en) | Process for preparing insulin compounds | |
AU2003212310A1 (en) | (4,2-disubstituted-thiazol-5-yl)amine compounds as pde7 inhibitors | |
AU5884700A (en) | Process for making amine compounds | |
HUP0500329A3 (en) | Process for making carbapenem compounds | |
HK1053648A1 (en) | Novel 1-(1-(hetero)aryl-1-perhydroxyalkylmethyl)-piperazine compounds, process for their preparationand medicaments containing these compounds | |
HUP0202379A3 (en) | New compounds, process for producing them and pharmaceutical compositions containing them | |
ZA200302159B (en) | New compounds derived from quinazoline, a process for their preparation and pharmaceutical compositions containing them. | |
AU2002306687A1 (en) | Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them | |
ZA200202220B (en) | Indenoindolone compounds, a process for their preparation and pharmaceutical compositions containing them. | |
EG24207A (en) | New benzothiazine and benazothiadizine compounds, a process for their preparation and pharmaceuticalcompositions containing them | |
ZA200202030B (en) | Isoindoloindolone compounds, a process for their preparation and pharmaceutical compositions containing them. | |
ZA200205598B (en) | Benzenesulphonamide compounds, a process for their preparation and pharmaceutical compositions containing them. | |
ZA200205666B (en) | N-benzylpiperazine compounds, a process for their preparation and pharmaceutical compositions containing them. | |
AU2002301141A1 (en) | Novel 1-[-(hetero)aryl-1-perhydroxyalkylmethyl])-piperazine compounds, process for their preparation and medicaments containing these compounds | |
HUP0001249A3 (en) | Novel substituted dimeric compounds, process for their production and medicaments containing the same | |
HK1053646A1 (en) | BenzoÄBÜpyranoÄ3,2-HÜacridin-7-one compounds, a process for their preparation and pharmaceutical compositions containing them | |
IL163334A (en) | Process for preparing 1-(mercaptomethyl)- cyclopropaneacetic acid and intermediate compounds for use therein | |
SG110170A1 (en) | New benzoindoline compounds, a process for their preparation and pharmaceutical compositions containing them | |
ZA200308265B (en) | Imidazoline compounds, a process for their preparation and pharmaceutical compositions containing them. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20110911 |